SCHEMBL2134609

SCHEMBL2134609

COC(=O)c1nc(Cl)c(Cl)c(NCc2ccccc2[N+](=O)[O-])c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.47
MAPT P10636 5/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
THRB P10828 1/20 0.46
KDM4E B2RXH2 2/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 5/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 1/20 0.44
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
PTPN1 P18031 1/20 0.41
LMNA P02545 1/20 0.40
ALDH3A1 P30838 1/20 0.39
PDE4A P27815 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2136360 0.90 SMN1; SMN2 (0.45) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2136542 0.88 MEN1 (0.45) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2140373 0.87 MEN1 (0.42) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2136708 0.86 MEN1 (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2139069 0.86 MEN1 (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2681602 0.81 MEN1 (0.47) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2137085 0.81 MAPT (0.44) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2137266 0.80 HTT (0.51) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL14686326 0.80 ALDH1A1 (0.44) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2138730 0.78 ALDH1A1 (0.44) SMN1; SMN2MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445884-B1 4-AMINOPICOLINATES AND THEIR USE AS HERBICIDES SYNGENTA LTD (GB) 2013-02-13 EP disclosed
EP-2445884-B1 4-AMINOPICOLINATES AND THEIR USE AS HERBICIDES SYNGENTA LTD (GB) 2013-02-13 EP disclosed
US-20120100990-A1 4 -AMINOPICOLINATES AND THEIR USE AS HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-04-26 US disclosed
US-20120100990-A1 4 -AMINOPICOLINATES AND THEIR USE AS HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-04-26 US disclosed
US-20120100990-A1 4 -AMINOPICOLINATES AND THEIR USE AS HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-04-26 US disclosed
WO-2010149956-A1 4 -AMINOPICOLINATES AND THEIR USE AS HERBICIDES SYNGENTA LIMITED (GB) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120100990-A1 4 -AMINOPICOLINATES AND THEIR USE AS HERBICIDES DDT, DAO, NPM1 SMN1; SMN2 3068/4885MAPT 1344/4885ALDH1A1 1297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.